SCHEMBL4756806

SCHEMBL4756806

CC(=O)Oc1c(Br)cccc1C(=O)Nc1nc(C/C=C/c2ccccc2)cs1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 8/20 0.46
PDE1A P54750 5/20 0.46
PDE1B Q01064 5/20 0.46
PDE1C Q14123 5/20 0.46
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
HPGD P15428 1/20 0.43
KDM4E B2RXH2 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
LMNA P02545 3/20 0.42
PKM P14618 1/20 0.41
MAPK1 P28482 3/20 0.40
SLC2A1 P11166 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4937272 0.81 SLC2A1 (0.39) PDE5APDE1APDE1BPDE1CALDH1A1
SCHEMBL4757488 0.73 SLC2A1 (0.41) PDE5APDE1APDE1BPDE1CALDH1A1
SCHEMBL4756640 0.67 GRM4 (0.50) ALDH1A1MEN1KMT2AHPGDKDM4E
SCHEMBL27792623 0.67 NPC1 (0.60) ALDH1A1HPGDKDM4ESMN1; SMN2PKM
SCHEMBL10114926 0.66 ALDH1A1 (0.38) PDE5APDE1APDE1BPDE1CALDH1A1
SCHEMBL12974234 0.66 SMN1; SMN2 (0.47) PDE5APDE1APDE1BPDE1CALDH1A1
SCHEMBL4756815 0.65 PDE5A (0.41) PDE5APDE1APDE1BPDE1CALDH1A1
SCHEMBL2154380 0.64 KDM4E (0.67) ALDH1A1HPGDKDM4ELMNAMAPK1
SCHEMBL4756354 0.64 RAB9A (0.50) PDE5APDE1APDE1BPDE1CALDH1A1
SCHEMBL4756826 0.64 RORC (0.43) PDE5APDE1APDE1BPDE1CALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC PDE5A 4694/4885PDE1A 4846/4885PDE1B 4830/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC PDE5A 4694/4885PDE1A 4846/4885PDE1B 4830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.